“Michael” reportedly hit $911.9M worldwide, overtaking “Bohemian Rhapsody” as top music biopic

Pitchfork reports that the film “Michael” has reportedly brought in $911.9 million worldwide. That number is not just a victory lap, it is a rank shift. By clearing $911.9 million, “Michael” has surpassed 2018’s “Bohemian Rhapsody” and become the highest-grossing music biopic in history, at least by this reported worldwide total.

If you are an executive watching this industry in real time, this is the part that matters: a studio does not only chase box office. It chases proof. When a film like “Michael” posts a worldwide haul of $911.9 million, it becomes a reference point for everything that follows. Acquisition teams benchmark it. Finance teams stress-test it. Boards and leadership groups use it as an anchor when debating budgets, talent spend, and release strategy for the next slate.

Music biopics occupy a unique lane in studio planning. They tend to sit at the intersection of star power, narrative packaging, and built-in audience demand. A biopic can look like “just another drama,” but the upside is structurally different: audiences often arrive with pre-existing emotional investment in the subject’s music, story, or era. That is why when one performer-led biopic moves into the category leader position, it can influence what gets funded across the entire subgenre. The industry does not treat these films as isolated bets. It treats them as signal generators.

This is also why surpassing “Bohemian Rhapsody” matters beyond trivia. “Bohemian Rhapsody” is a 2018 benchmark in the same category, so “Michael” is not just winning. It is beating the closest modern comp with a clear, comparable genre label. In practice, that can tighten the decision loop for stakeholders who need to justify spending. If leadership wants to argue that music biopics are still culturally and commercially alive, a new top performer gives them a cleaner story than vague optimism.

On the incentives side, executives are rewarded for repeatable patterns. A $911.9 million worldwide performance can change the internal math for greenlights, even if any single project will always be different. Studios may push for scripts that are more “event-like,” or for casting and production choices that reduce perceived uncertainty. Marketing teams can also gain leverage because a category leader can be marketed as more than a biographical film. It becomes a must-see moment, and that can affect how distributors allocate screens and attention.

There is a second-order implication for boards and finance teams: category leadership can compress the risk tolerance window. When the market appears to have a strong appetite for a proven format, leadership may feel pressure to fund more of the same. That can be rational if the studio has identified what the audience rewarded. But it can also create a trap: chasing the last winner’s shape too aggressively. When a single film sets a new ceiling, it can encourage overconfidence in the next project, particularly if those projects share similarities that are more superficial than strategic.

And then there is the regulatory and compliance dimension that always hovers over entertainment deals, even when the headline is box office. While the source here focuses on worldwide gross, the broader industry reality is that studios must still navigate rights clearance, licensing, and legal frameworks tied to real-world music and likeness. High-performing films can increase scrutiny over how rights were secured, how content claims were handled, and how audiences and licensors respond to portrayals. The better the financial outcome, the more valuable those rights and the more intensely parties will want clarity in future transactions.

For peers and decision-makers considering a music-biopic-heavy strategy, the takeaway is straightforward: “Michael” reportedly reached $911.9 million worldwide and overtook “Bohemian Rhapsody” as the highest-grossing music biopic. That is a new reference number in the industry’s decision-making toolbox. If you are evaluating slate risk, talent spend, or the timing of releases, this reported performance gives you a concrete benchmark for what “audiences will fund” in this genre. It also sets a higher bar for everyone else trying to be the next category leader.